newsfilter
← Latest News
GlobeNewswire·

Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference

Reaching more mUM patients globally with KIMMTRAK (tebentafusp) in 2025 through additional launches and increased community penetration Enrolling three Phase 3 trials across multiple melanoma indications – potential